(Q46323741)

21 December 2017

title

The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer (English)

1 reference

21 December 2017

0 references

1 reference

Mudan Lu

1

1 reference

21 December 2017

Yueming Zhao

2

1 reference

21 December 2017

Fei Xu

3

1 reference

21 December 2017

Yong Wang

4

1 reference

21 December 2017

Jingying Xiang

5

1 reference

21 December 2017

Daozhen Chen

6

1 reference

21 December 2017

language of work or name

1 reference

20 June 2012

1 reference

21 December 2017

published in

Medical Oncology

1 reference

21 December 2017

volume

29

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

3409-3415

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s12032-012-0275-z

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Epidemiological and molecular aspects of ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

FOXOs, cancer and regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Functional interaction between FOXO3a and ATM regulates DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Dynamic FoxO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Ubiquitin ligases: cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Akt activation promotes degradation of tuberin and FOXO3a via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0275-Z

Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2

21 January 2018

1 reference

12 December 2020

Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex

1 reference

12 December 2020

Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.

1 reference

12 December 2020

Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients

1 reference

12 December 2020

10.1007/S12032-012-0275-Z

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017